We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India
News

PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India

PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India
News

PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PerkinElmer, Inc. has announced that it has acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd., a laboratory in India that focuses on fetal, maternal and newborn health.

Surendra Genetics Labs was founded by Dr. S. Suresh, a leading fetal medicine expert and ultrasonologist. The laboratory is based in Chennai, India and provides testing services for pregnant mothers and newborns.

Ann-Christine Sundell, president, Genetic Screening, PerkinElmer, said, "The acquisition of Surendra Labs is a key component of PerkinElmer's global commitment to facilitate access to advanced fetal, maternal and child health screening and diagnostic technologies and services for the Indian public and clinicians. This will enable PerkinElmer to extend our offerings to ensure better health outcomes in pregnancy and of newborns, as well as introduce new technologies to the India market."
Advertisement